Skip to Content

Tag Archives: pharmaceuticals

Pfizer Under the Microscope

I’m not, ordinarily, a fan of big companies’ annual reports. There’s way too much puffery, and far too little substance. However, I’m intrigued by an exception this year. Pfizer (NYSE: PFE), under the gun from regulators, investors and various other constituencies, has put out a remarkable little booklet called Ten Questions. In the report, the company tries to address, head-on, some of the sharpest criticisms leveled against itself and the pharmaceutical industry.

ANYBODY FOR DRUGS?

In the midst of this new bull market, one group of stocks is writhing in pain: pharmaceuticals. Are we hearing a death knell — or is it a dinner bell?

I’m inclined to press the button for Option #2. Granted, all the major drug makers are facing issues with patent expirations in the next couple of years.